Cellceutix Garners $1,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8e919e5-0566-42ca-a7cc-8af87f2d01f1&Preview=1 -
Date
5/11/2012 -
Company Name
Cellceutix -
Mailing Address
100 Cumming Center Beverly, MA 01915 -
Company Description
Cellceutix Corporation is an emerging bio-pharmaceutical company in the business of developing small molecule therapies in areas of unmet medical need. Our primary efforts are in cancer and inflammatory disease. We intend to spend most of our time initially on our lead product, Kevetrin, which is being developed for drug-resistant cancers. -
Website
http://www.cellceutix.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
